Fig. 3From: A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipientsEfficacy of DCV/SOF treatment. HCV-RNA viral load in 16 HCV-positive KTR over the treatment period with DCV/SOFBack to article page